Complex Sleep Apnea Syndrome Clinical Trial
Official title:
Observational and Transversal Study of Patients Treated in "Real Life"Conditions With Adaptive Servo-Ventilation
Adaptive Servo-Ventilation (ASV) treatment is routinely prescribed in France. In order to be reimbursed according to the French Social Security rules, the patient treated with an ASV needs to be examined each year. In this observational transversal single-visit study, the investigators aim to describe the clinical characteristics of patients treated with ASV and the associated device settings.
The purpose of this study is to evaluate in "real life conditions" the use of Adaptative
Servo-Ventilation (ASV) treatment. ASV treatment is routinely prescribed in France in
patients with various sleep disorders breathing (Chronic Heart Failure (CHF) and Central
Sleep Apnea Syndrome (CSAS), CHF and central and obstructive sleep apnea (COSA), Obstructive
Sleep Apnea Syndrome (OSAS) and complex sleep apnea syndrome (compSAS), idiopathic or drug
induced periodic breathing.
In order to be reimbursed according to the French Social Security rules, the patient treated
with an ASV needs to be examined each year. In this observational transversal single-visit
study, the aim is to describe the clinical characteristics of patients treated with ASV and
the associated device settings. The aim is to evaluate the safety and efficacy issues in real
life conditions of the ASV prescription.Depending of the data, data are obtained after
analysis of the six latest months data of the ASV device, after questioning the patient,
after analysis of the polygraphy/oximetry (if prescribed by the doctor for the renewal
consultation of the ASV care and reimbursement by the French Social Security). All the data
are obtained during the annual consultation required by the French Social Security.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00915499 -
Complex Sleep Apnea Syndrome (CompSAS) Resolution Study
|
N/A |